NOVEL ANTIBODY THERAPY HOLDS POTENTIAL FOR KIDNEY CANCER TREATMENT
KUALA LUMPUR, Even with new immunotherapies, only around one in 10 patients ultimately survive from advanced clear cell renal cell carcinoma (ccRCC), a deadly form of kidney cancer with few treatment options.
Currently, The Wistar Institute scientis…